Mindful Self-Compassion Therapy for Borderline Personality Disorder
Impact of Mindful Self-Compassion Therapy on Self Harm Behaviors, Emotional Regulation and Quality of Life Among Patients With Borderline Personality Disorder: A Randomized Controlled Trial
This study is testing whether Mindful Self-Compassion therapy can help people with Borderline Personality Disorder feel better by reducing self-harm and improving their emotional well-being and quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fatima Jinnah Women University Academic / other |
| Locations | 2 sites (Rawalpindi, Punjab Province and 1 other locations) |
| Trial ID | NCT06699732 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of Mindful Self-Compassion (MSC) therapy on individuals diagnosed with Borderline Personality Disorder (BPD). It consists of two phases: a cross-sectional survey to assess various psychological factors, followed by a randomized controlled trial where participants are divided into an intervention group receiving MSC therapy and a waitlist control group. The study aims to evaluate changes in self-harm behaviors, emotional regulation, and quality of life before and after the intervention. The findings are expected to provide valuable insights into the efficacy of MSC therapy for treating BPD.
Who should consider this trial
Good fit: Ideal candidates are non-hospitalized adults aged 18 and above, diagnosed with Borderline Personality Disorder and experiencing psychological distress.
Not a fit: Patients with other chronic co-morbid diseases or those younger than 18 years may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could significantly reduce self-harm behaviors and improve emotional well-being and quality of life for patients with BPD.
How similar studies have performed: Previous studies have shown promising results for mindfulness-based therapies in treating emotional dysregulation, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\. First time diagnosed non-hospitalized patients of Borderline Personality Disorder. 2\. Patients of Borderline Personality Disorder experiencing psychological distress,low level of quality of life, social support, emotional dysregulation would be included. 3\. Borderline Personality Disorder patients with age 18 years and above (both gender) from outpatient department (OPD) 4. Borderline personality patients who would be able to understand Urdu language and can give the informed consent * Exclusion criteria The study would have the following exclusion criteria: 1. Hospitalized patients of Borderline Personality 2. Patients with Borderline Personality having other chronic co-morbid diseases such as cancer, cognitive deficits, and other chronic psychological disorders. 3. Patients with Borderline Personality younger than 18 years of age
Where this trial is running
Rawalpindi, Punjab Province and 1 other locations
- Commandant Afimh — Rawalpindi, Punjab Province, Pakistan (Recruiting)
- Farid Family Hospital — Rawalpindi, Punjab Province, Pakistan (Recruiting)
Study contacts
- Principal investigator: Asma Mansoor, PhD Scholar — Fatima Jinnah Women University, Rawalpindi, Pakistan
- Study coordinator: Asma Mansoor, PhD Scholar
- Email: asmansoor31@yahoo.com
- Phone: +923365374633
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.